Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...
In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It ...
There's promising new research to report in efforts to reverse baldness: A new study shows how restorative hair growth can be triggered in mice within 20 days, by stimulating fat cells around hair ...
In 2023, the worldwide clean energy market was estimated to be about $0.7 trillion, according to a report from Allied Market ...
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
The Brighterside of News on MSN
New molecule targets and destroys harmful RNA linked to cancer and aging
Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.
All over the world people are ageing more rapidly and succumbing to diseases that typically affected the elderly. But there are ways to turn back the clock on your biological age ...
Berries are rich in antioxidants and flavonoids such as anthocyanins, which are anti-inflammatory and can reduce oxidative stress. "These two factors are major drivers of cancer, and berries pack a ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Before dawn the morning of Halloween, residents of a quaint, tree-lined Michigan neighborhood were jolted awake to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results